125 related articles for article (PubMed ID: 30612076)
1. Factors predicting uncontrolled seizures in epilepsy with auditory features.
Zhang L; Zhu X; Zou X; Chen L
Seizure; 2019 Feb; 65():55-61. PubMed ID: 30612076
[TBL] [Abstract][Full Text] [Related]
2. Lamotrigine versus carbamazepine monotherapy for epilepsy.
Gamble CL; Williamson PR; Marson AG
Cochrane Database Syst Rev; 2006 Jan; (1):CD001031. PubMed ID: 16437428
[TBL] [Abstract][Full Text] [Related]
3. Oxcarbazepine versus phenytoin monotherapy for epilepsy.
Muller M; Marson AG; Williamson PR
Cochrane Database Syst Rev; 2006 Apr; (2):CD003615. PubMed ID: 16625587
[TBL] [Abstract][Full Text] [Related]
4. Antiepileptic drugs for seizure control in people with neurocysticercosis.
Sharma M; Singh T; Mathew A
Cochrane Database Syst Rev; 2015 Oct; (10):CD009027. PubMed ID: 26455722
[TBL] [Abstract][Full Text] [Related]
5. Carbamazepine treatment of generalized tonic-clonic seizures in idiopathic generalized epilepsy.
Kenyon K; Mintzer S; Nei M
Seizure; 2014 Mar; 23(3):234-6. PubMed ID: 24370318
[TBL] [Abstract][Full Text] [Related]
6. Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy.
Powell G; Saunders M; Marson AG
Cochrane Database Syst Rev; 2010 Jan; (1):CD007124. PubMed ID: 20091617
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy.
Fakhoury TA; Hammer AE; Vuong A; Messenheimer JA
Epilepsy Behav; 2004 Aug; 5(4):532-8. PubMed ID: 15256191
[TBL] [Abstract][Full Text] [Related]
8. Carbamazepine versus phenytoin monotherapy for epilepsy.
Tudur Smith C; Marson AG; Clough HE; Williamson PR
Cochrane Database Syst Rev; 2002; (2):CD001911. PubMed ID: 12076427
[TBL] [Abstract][Full Text] [Related]
9. Predictors of drug-resistance in epilepsy with auditory features.
Zhang L; Zhu X; Peng A; Lai W; He S; Qiu X; Zou X; Chen L
Epilepsy Res; 2020 Aug; 164():106353. PubMed ID: 32447239
[TBL] [Abstract][Full Text] [Related]
10. Polytherapy, monotherapy, and carbamazepine.
Reynolds EH
Epilepsia; 1987; 28 Suppl 3():S77-80. PubMed ID: 3319545
[TBL] [Abstract][Full Text] [Related]
11. Vigabatrin versus carbamazepine monotherapy for epilepsy.
Xiao Y; Gan L; Wang J; Luo M; Luo H
Cochrane Database Syst Rev; 2012 Jan; 1():CD008781. PubMed ID: 22258989
[TBL] [Abstract][Full Text] [Related]
12. Carbamazepine versus phenobarbitone monotherapy for epilepsy.
Tudur Smith C; Marson AG; Williamson PR
Cochrane Database Syst Rev; 2003; (1):CD001904. PubMed ID: 12535420
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of phenytoin, valproic acid, carbamazepine and new antiepileptic drugs on control of late-onset post-stroke epilepsy in Taiwan.
Huang YH; Chi NF; Kuan YC; Chan L; Hu CJ; Chiou HY; Chien LN
Eur J Neurol; 2015 Nov; 22(11):1459-68. PubMed ID: 26148132
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy and tolerability of carbamazepine as the initial drug used in the treatment of epilepsy].
Zubcević S; Gavranović M; Katica V; Brajković D; Catibusić F
Med Arh; 2002; 56(3 Suppl 1):26-9. PubMed ID: 12762240
[TBL] [Abstract][Full Text] [Related]
15. New statistical method for analyzing time to first seizure: example using data comparing carbamazepine and valproate monotherapy.
Cowling BJ; Shaw JE; Hutton JL; Marson AG
Epilepsia; 2007 Jun; 48(6):1173-8. PubMed ID: 17553118
[TBL] [Abstract][Full Text] [Related]
16. Association of drug levels & pharmacokinetics of carbamazepine with seizure control.
Vasudev A; Tripathi KD; Puri V
Indian J Med Res; 2000 Dec; 112():218-23. PubMed ID: 11247200
[TBL] [Abstract][Full Text] [Related]
17. Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.
Baulac M; Rosenow F; Toledo M; Terada K; Li T; De Backer M; Werhahn KJ; Brock M
Lancet Neurol; 2017 Jan; 16(1):43-54. PubMed ID: 27889312
[TBL] [Abstract][Full Text] [Related]
18. PCDH19-related female-limited epilepsy: further details regarding early clinical features and therapeutic efficacy.
Higurashi N; Nakamura M; Sugai M; Ohfu M; Sakauchi M; Sugawara Y; Nakamura K; Kato M; Usui D; Mogami Y; Fujiwara Y; Ito T; Ikeda H; Imai K; Takahashi Y; Nukui M; Inoue T; Okazaki S; Kirino T; Tomonoh Y; Inoue T; Takano K; Shimakawa S; Hirose S
Epilepsy Res; 2013 Sep; 106(1-2):191-9. PubMed ID: 23712037
[TBL] [Abstract][Full Text] [Related]
19. LGI1-antibody associated epilepsy successfully treated in the outpatient setting.
Uribe-San-Martín R; Ciampi E; Santibañez R; Irani SR; Márquez A; Cruz JP; Soler B; Miranda MC; Henríquez M; Cárcamo C
J Neuroimmunol; 2020 Aug; 345():577268. PubMed ID: 32480242
[TBL] [Abstract][Full Text] [Related]
20. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
